Search Results - "Davies, J.C"

Lung clearance index: Evidence for use in clinical trials in cystic fibrosis by Kent, L, Reix, P, Innes, J.A, Zielen, S, Le Bourgeois, M, Braggion, C, Lever, S, Arets, H.G.M, Brownlee, K, Bradley, J.M, Bayfield, K, O'Neill, K, Savi, D, Bilton, D, Lindblad, A, Davies, J.C, Sermet, I, De Boeck, K

“…Abstract The ECFS-CTN Standardisation Committee has undertaken this review of lung clearance index as part of the group's work on evaluation of clinical…”
Get full text

Stabilising Oxide Core—Platinum Shell Catalysts for the Oxygen Reduction Reaction by Davies, J.C., Hayden, B.E., Offin, L.

“…[Display omitted] Thin film planar models of core-shell catalysts for the oxygen reduction reaction in PEM fuel cells, have been synthesised with tin doped…”
Get full text

Variability of sweat chloride concentration in subjects with cystic fibrosis and G551D mutations by Vermeulen, F, Le Camus, C, Davies, J.C, Bilton, D, Milenković, D, De Boeck, K

“…Abstract Introduction Sweat chloride concentration, a biomarker of CFTR function, is an appropriate outcome parameter in clinical trials aimed at correcting…”
Get full text

WS07.4 Combined killing effects of lytic bacteriophages and antibiotics in biofilm-grown Pseudomonas aeruginosa from CF airway cultures by Martin, I, Davies, J.C, Morales, S, Alton, E.W

Get full text

WS07.7 Response of Pseudomonas aeruginosa to hypochlorous acid (HOCl) stress and the role of defence mechanisms in protecting against neutrophil killing by Farrant, K.V, Davies, J.C, Williams, H.D

Get full text

WS15.1 Further comparison of lung clearance index (LCI) generated with SF6 and N2 -based multiple breath washout (MBW) techniques: differences increase with disease severity and are predominantly related to the prolonged final stage of the N2 washout by Bayfield, K.J, Alton, E.W.F.W, Horsley, A, Davies, J.C

Get full text

134 Training and qualifying international teams in standardised procedures: steps on the learning curve from the CTN LCI Core Facility by Saunders, C, Bayfield, K.J, Short, C, Davies, J.C

Get full text

104 Clinical impact of Staphylococcus aureus co-infection in sputum-producing cystic fibrosis patients chronically infected with Pseudomonas aeruginosa by Palau, H. Lund, Simbo, A, Turnbull, A, Jones, A, Davies, J.C

Get full text

196 The impact of pH on antibiotic susceptibility of clinical Pseudomonas aeruginosa strains by Murphy, R.A, Simbo, A, Pallant, L, Bardin, G, Davies, J.C

Get full text

WS14.6 Increased respiratory syncytial virus burden leads to more rapid cell death in Phe508del bronchial epithelial cells by Coates, M.S, Alton, E.W.F.W, Brookes, D.W, Ito, K, Davies, J.C

Get full text

ePS04.3 Comparison of CF and non-CF LCI results using the Exhalyzer D and Innocor™ devices by Bayfield, K.J, Saunders, C, Alton, E, Davies, J.C

“…Background Multiple breath washout (MBW) is a pulmonary function test that allows measurement of lung clearance index (LCI), a marker of ventilation…”
Get full text

87 Pseudomonas aeruginosa from CF patients form larger biofilms in vitro than those from subjects with bronchiectasis by Smith, W.D, Murphy, R.A, Simbo, A, Hogg, C, Filloux, A, Bush, A, Davies, J.C

Get full text

224 Is paediatric home monitoring in CF feasible? There's an app for that by Edmondson, C, Westrupp, N, Bush, A, Alton, E.W, Brownlee, K, Davies, J.C

Get full text

Gabapentin and pregabalin to treat aggressivity in dementia: a systematic review and illustrative case report by Supasitthumrong, Thitiporn, Bolea‐Alamanac, Blanca M., Asmer, Selim, Woo, Vincent L., Abdool, Petal S., Davies, Simon J.C.

“…Aims The prevalence of dementia is rising as life expectancy increases globally. Behavioural and psychological symptoms of dementia (BPSD), including agitation…”
Get full text

WS16.2 The prevalence of gastroesophageal reflux disease in infants with cystic fibrosis diagnosed by newborn screening and the relationship with lung infection by Thursfield, R, Ravindran, R, Bush, A, Davies, J.C, Carr, S.B

“…Gastro-oesophageal reflux disease (GORD) has been implicated in the respiratory symptoms of CF. Studies in small populations suggest GORD may be present in up…”
Get full text

90 Using cell-free biosensors to monitor Pseudomonas aeruginosa infection in cystic fibrosis sputum by Cameron, L, Wen, K.Y, Chappell, J, Jensen, K, Bell, D, Kelwick, R, Kopniczky, M, Davies, J.C, Filloux, A, Freemont, P

Get full text

WS13.4 Efficacy and safety of lumacaftor/ivacaftor (LUM/IVA) in patients (pts) aged 6–11 years (yrs) with cystic fibrosis (CF) homozygous for F508del-CFTR : a randomized placebo (PBO)-controlled phase 3 trial by Ratjen, F, Tian, S, Marigowda, G, Hug, C, Huang, X, Stanojevic, S, Milla, C.E, Robinson, P, Waltz, D, Davies, J.C

Get full text

93 Determining the impact of the T2R38 bitter taste receptor on P. aeruginosa infection in the cystic fibrosis airway by Turnbull, A, Shoemark, A, Palau, H. Lund, Murphy, R.A, Simbo, A, Bush, A, Alton, E.W, Davies, J.C

Get full text

Fair selection of participants in clinical trials: The challenge to push the envelope further by Davies, J.C, Scott, S, Dobra, R, Brendell, R, Brownlee, K, Carr, S.B, Cosgriff, R, Simmonds, N.J, Jahan, R, Jones, A, Matthews, J, Brown, S, Galono, K, Miles, K, Pao, C, Shafi, N, Watson, D, Orchard, C, Davies, G, Pike, K, Shah, S, Bossley, C.J, Fong, T, Macedo, P, Ruiz, G, Waller, M, Baker, L

Get full text

WS01.5 An open-label study of the safety, pharmacokinetics, and pharmacodynamics of ivacaftor in patients aged 2 to 5 years with cystic fibrosis and a CFTR gating mutation: The KIWI study by Rosenfeld, M, Robertson, S, Green, Y, Cooke, J, Lawal, A, Davies, J.C

“…Background Ivacaftor potentiates CFTR chloride transport and improves outcomes in patients ≥6 y with CF and a CFTR gating mutation. This 2-part study evaluated…”
Get full text